MEDICINES CO [THE] MDCO (NASDAQ)

$ 19.72
19:09
Sponsored by
Click here!
Change: -1.38 (-6.54%)
Volume: 1,521,500

Avg. Volume: 1122600
P/E Ratio: 0
EPS (Annual): -0.26
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 52,010
Institutional Shareholders: 95.06%
Last: 19.72
Change: -1.38 (-6.54%)
Prev. Close: 21.10
Open: 20.77
Day's Range: 18.38 - 21.24
52wk Range: 16.38 - 28.00
Market Value: 1,098,930
Beta: .54
12-month EPS Change: -71.01%
Total Return Last 12 Months: +1.54%
Total Return Last 3 Years: +19.57%
Total Return Last 5 Years: -23.74%
5-Year Revenue Growth Rate: 572.40%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: -71.54%


Headlines on MDCO
Alert me Subscribe

FDA approves Medicines Co.'s blood-pressure drug

(PARSIPPANY, N.J.)Pharmaceutical maker Medicines Co. said Monday it received federal approval to market its drug Cleviprex for patients with difficult-to-treat high blood pressure.READ MORE
Aug 04, 2008 10:21AM
Keywords: MDCO

Medicines hopeful on drug patent extension

(NEW YORK)Drug developer Medicines Co. could gain a patent extension on its blood thinner product Angiomax, following a measure by the House of Representatives earlier this week.READ MORE
Jun 25, 2008 2:07PM
Keywords: MDCO

Medicines Co. Shares Fall after FDA Rejects Angiomax

The Medicines Company said on a press release on Wednesday that it received a not approvable letter from U.S. regulators on a supplemental New Drug Application for an additional do...READ MORE
May 28, 2008 6:49PM
Keywords: MDCO

Expanded use of Medicines blood thinner rejected

(PARSIPPANY, N.J.)Medicines Co. said Wednesday the Food and Drug Administration rejected its application to expand use of its blood thinner Angiomax to include acute coronary syndromes in emergency ...READ MORE
May 28, 2008 10:27AM
Keywords: MDCO

Earnings roundup: Anheuser-Busch, Medicines

Among the earnings stories for Wednesday, April 23, from AP Financial News: Top stories:READ MORE
Apr 23, 2008 4:26PM
Keywords: BUD, MDCO, PM, MO, NWPX, MPX

Medicines 1Q earnings surge 59 percent on strong US sales

(PARSIPPANY, N.J.)Drug company Medicines Co. said Wednesday that first-quarter earnings surged 59 percent, topping Wall Street expectations, on strong U.S. sales growth of its blood thinner Angiomax...READ MORE
Apr 23, 2008 1:37PM
Keywords: MDCO

Medicines Co. Paid Lobbyist $600,000

(WASHINGTON)Medicines Co. paid lobbying and law firm King & Spalding $600,000 in 2007 to lobby for a change to patent-filing rules. In 2001, Medicines missed a non-extendable deadline to file ...READ MORE
Mar 06, 2008 2:03PM
Keywords: MDCO
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN -15.10 48.58
GILEAD SCIENCES -26.60 37.47
GENENTECH INC -9.90 73.00
CELGENE CP -26.70 54.52
BIOGEN IDEC INC -34.90 42.78